Marie Jardine-Yeats

Marie Jardine-Yeats has a comprehensive work experience in the pharmaceutical industry. Marie is currently serving as the Vice President of Quality Assurance at Lyndra Therapeutics since April 2020. Previously, they worked at Alkermes for a significant duration, starting in 2001. At Alkermes, they held various roles, including Director of Development QA, Associate Director of Development QA, QA Specialist - Development QA, Manager, Quality, Supervisor, Quality Assurance, Senior Quality Assurance Operations Associate, and Senior Clinical Manufacturing Associate. During their tenure at Alkermes, Marie managed all aspects of Quality, including QA training, documentation, site GMP compliance, and oversight of third-party providers for global clinical trial operations. Marie supported external operations teams and ensured oversight of API and drug substance manufacturing organizations, as well as drug product formulation, labeling, packaging, and distribution vendors. Marie worked with a variety of product types, including solid dosage forms, sterile injectable, drug-device combination products, biologics, DEA scheduled, and high-potency compounds. Prior to their time at Alkermes, Marie also gained experience at Goodwin Biotechnology, Inc. as a Cell Culture Technician, and at Chiron Diagnostics / Bayer Diagnostics as a Reagent Manufacturing Technician II. Marie started their career at EMD Serono, Inc. as a Manufacturing Associate in Cell Culture. Throughout their career, Marie has shown expertise in quality assurance, manufacturing, and compliance in the pharmaceutical industry.

Marie Jardine-Yeats's education history begins with their completion of a Bachelor of Arts degree in Biology, General from Regis College in 1995. Marie later pursued further education at the University of Strathclyde, where they obtained a Master of Science degree in Pharmaceutical Quality and Good Manufacturing Practice. The specific start year for their Master's degree is not provided.